i-SENS, Inc.

KOSDAQ 099190.KQ

i-SENS, Inc. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -48.99 M

i-SENS, Inc. Net Cash Used For Investing Activities is USD -48.99 M for the year ending December 31, 2023, a -460.72% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

i-SENS, Inc. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD 13.58 M, a 134.37% change year over year.
i-SENS, Inc. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -39.51 M, a 5.61% change year over year.
i-SENS, Inc. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -41.86 M, a -106.15% change year over year.
i-SENS, Inc. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -20.31 M, a -73.48% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

KOSDAQ: 099190.KQ

i-SENS, Inc.

CEO	Dr. Geun-Sig Cha
IPO Date	Jan. 30, 2013
Location	South Korea
Headquarters	43, Banpo-daero 28-gil
Employees	687
Sector	Consumers Staples
Industries Personal Care Biotechnology Frozen Foods Hardware & Electronics Medical Instruments Non-Alcoholic Beverages Pharmaceuticals Telehealth

Description

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years